THOUSAND OAKS, Calif.,
May 28, 2020 /PRNewswire/ -- Amgen
(NASDAQ: AMGN) will present at the Jefferies 2020 Virtual
Healthcare Conference at 4:00 p.m. ET on
Tuesday, June 2, 2020. David
M. Reese, M.D., executive vice president of Research and
Development at Amgen, will be leading the presentation. Live audio
of the fireside chat can be accessed from the Events Calendar on
Amgen's website, www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for 90 days
following the event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631
(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-jefferies-2020-virtual-healthcare-conference-301067373.html
SOURCE Amgen